1209MO Neoadjuvant nivolumab and nivolumab+ipilimumab in resectable non-small cell lung cancer: Combined analysis of 5-year outcomes from NEOSTAR and CA209-159
| Autor: | Reuss, J., Leung, C.H., Rosner, S., Zhou, N., Weissferdt, A., Pataer, A., Nassib William Junior, W., Taube, J., Broderick, S., Spicer, J.D., Jones, D.R., Gibbons, D., Heymach, J.V., Anagnostou, V., Lin, H., Lee, J.J., Sepesi, B., Chaft, J., Forde, P.M., Cascone, T. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S776-S777 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|